Publication |
PUBMEDID |
Hoover WC, Zhang W, Xue Z, Gao H, Chernoff J, et al. Inhibition of p21 Activated Kinase (PAK) Reduces Airway Responsiveness In Vivo and In Vitro in Murine and Human Airways. PLoS ONE 2012 Aug; 7(8): e42601. doi:10.1371/journal.pone.0042601 |
22900031 |
Rosenfeld M, Ratjen F, Brumback L, Daniel S, Rowbotham R, McNamara S, Johnson R, Kronmal R, Davis SD, Isis Study Group FT (Hoover W, member); Inhaled Hypertonic Saline in Infants and Children Younger Than 6 Years With Cystic Fibrosis: The ISIS Randomized Controlled TrialInhaled Hypertonic Saline in Children With CF. JAMA. 2012 May 20:1-9. doi: 10.1001/jama.2012.5214. |
22610452 |
Troxler RB, Hoover WC, Britton LJ, Gerwin AM, and Rowe SM. Eradication of Mucoid Pseudomonas aeruginosa in patients with Cystic Fibrosis: A Retrospective Annalysis. Pediatr Pulmonol. 2012 Apr 11. doi: 10.1002/ppul.22543. |
22496040 |
Hoover W, Britton LJ, Garder J, Jackson T, and Gutierrez HH. Rapid Onset of Iatrogenic Adrenal Insufficiency in a Patient With Cystic Fibrosis Related Liver Disease Treated With Inhaled Corticosteroids and a Moderate CYP3A4 Inhibitor. Ann Pharmacother. 2011 Jul;45(7-8):e38. |
21712512 |
Flume PA, Mogayzel PJ Jr, Robinson KA, Rosenblatt RL, Quittell L, Marshall BC; Clinical Practice Guidelines for Pulmonary Therapies Committee (Hoover W, - member); Cystic Fibrosis Foundation Pulmonary Therapies Committee. Cystic fibrosis pulmonary guidelines: pulmonary complications: hemoptysis and pneumothorax. Am J Respir Crit Care Med. 2010 Aug 1;182(3):298-306. |
20675678 |
Hoover W, Ackerman V, Schamberger M, Kumar M, Marshalleck F, Hoyer M. Congenital Porto-caval Fistula: An Unusual Presentation and Novel Intervention. Pediatr Pulmonol. 2008 Feb;43(2):196-9. |
18085682 |
Nebesio TD, Hoover WC, Caldwell RL, Nitu ME, Eugster EA. Life-Threatening Complications of Diazoxide Therapy in an Infant with Hyperinsulinism - A Case Report and Review of the Literature. J Pediatr Endocrinol Metab. 2007 Aug;20(8):939-44. |
17937066 |
Hoover W, Clancy JP. “New Horizons in CF Therapy.” US Respiratory Disease. 2011; 7 (1): 20-25. |
|
Hoover W, Clancy JP. Targeting early events in cystic fibrosis disease pathogenesis. Drugs Fut 2011, 36(2): 133 |
|
|
|